Inequalities in initiation of COVID19 vaccination by age and population group in Israel- December 2020-July 2021
Open Access
- 30 October 2021
- journal article
- research article
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 12, 100234
Abstract
No abstract availableKeywords
All Related Versions
This publication has 10 references indexed in Scilit:
- COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 15, 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Israel’s rapid rollout of vaccinations for COVID-19Israel Journal of Health Policy Research, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trialThe Lancet, 2020
- Vaccine hesitancy: the next challenge in the fight against COVID-19European Journal of Epidemiology, 2020
- Timeliness and completeness of routine childhood vaccinations in young children residing in a district with recurrent vaccine-preventable disease outbreaks, Jerusalem, IsraelEurosurveillance, 2019
- Population-level factors predicting variation in influenza vaccine uptake among adults and young children in England, 2015/16 and 2016/17Vaccine, 2018
- Predictors of coverage of the national maternal pertussis and infant rotavirus vaccination programmes in EnglandEpidemiology and Infection, 2017
- Measles outbreaks affecting children in Jewish ultra-orthodox communities in JerusalemEpidemiology and Infection, 2007